WinSanTor
Growth Stage
Ensuring no one suffers from Peripheral Neuropathy.
Overview
Raised: $596,649
Total Commitments ($USD)
Platform
Wefunder
Start Date
09/28/2018
Close Date
03/20/2019
Min. Goal
$300,000
Max. Goal
$1,070,000
Min. Investment
$500
Security Type
SAFE
SEC Filing Type
RegCF
Valuation Cap
$70,000,000
Discount
25%
Rolling Commitments ($USD)
Status
Funded
Reporting Date
03/31/2019
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$3,449
# of Investors
285
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2011
Industry
Healthcare & Pharmaceuticals
Tech Sector
Location
San Diego, California
Winsantor is here to make sure that no one suffers from peripheral neuropathy (PN). PN affects 1 in 15 people in the US, and it’s when the nerves die due to disease, injuries, cancer, or genetic diseases. There is currently no treatment -- just drugs that help reduce the pain. Winsantor, however, is currently in trials that show they be on track to reverse the disease, both biologically and functionally. So far, over $30M of non-dilutive funding has driven R&D; they are currently entering Phase 2 of early efficacy studies; and they aim to have their drug approved by 2021 to start helping -- and changing -- the lives of those who are affected.
Create a free account today to gain access to KingsCrowd analytics.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.